-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Prelude Therapeutics Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q2 2021 to Q3 2024.
- Prelude Therapeutics Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 75.9M shares, a 12.1% increase year-over-year.
- Prelude Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 60.4M shares, a 27.4% increase from 2022.
- Prelude Therapeutics Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 47.4M shares, a 2.87% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)